GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILLF) » Definitions » Revenue

WILLF (Demant AS) Revenue : $3,190 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Demant AS Revenue?

Demant AS's revenue for the six months ended in Dec. 2024 was $1,591 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $3,190 Mil. Demant AS's Revenue per Share for the six months ended in Dec. 2024 was $7.38. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $14.69.

Good Sign:

Demant AS has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Demant AS was 6.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Demant AS's highest 3-Year average Revenue per Share Growth Rate was 17.10% per year. The lowest was 5.50% per year. And the median was 10.75% per year.


Demant AS Revenue Historical Data

The historical data trend for Demant AS's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS Revenue Chart

Demant AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,365.99 2,720.71 2,805.82 3,160.44 3,147.81

Demant AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,453.53 1,556.19 1,595.80 1,599.03 1,591.10

Competitive Comparison of Demant AS's Revenue

For the Medical Devices subindustry, Demant AS's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Demant AS's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's Revenue distribution charts can be found below:

* The bar in red indicates where Demant AS's Revenue falls into.



Demant AS Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $3,190 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Demant AS  (OTCPK:WILLF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Demant AS Revenue Related Terms

Thank you for viewing the detailed overview of Demant AS's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Demant AS Business Description

Address
Kongebakken 9, Smorum, DNK, 2765
Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.